Economic analysis of esophageal stenting for management of malignant dysphagia.

Over half of patients diagnosed with esophageal cancer are unsuitable for curative resection. A significant proportion of these patients will subsequently require palliative stenting to alleviate dysphagia. There is growing consensus in the literature that the deployment of a Self-Expanding Metal Stent is the optimum stenting strategy; however, it remains unclear whether covered or uncovered metal stents are more cost-effective. In order to determine which type of prosthesis is more cost-effective, we compared the different stenting strategies in terms of 1-year stent-related mortality, health-related quality of life, and cost. A decision analytical model was constructed to compare the 1-year stent-related mortality, health-related quality of life, and cost between covered and uncovered stents. Probabilistic sensitivity analysis was performed to quantify the uncertainty associated with our results. Value of Information analysis was performed to assess the value of further research. In order to fully characterize the uncertainty associated with this decision, plastic stents were included in our analysis. Stent-related mortality was slightly lower following covered stent deployment compared with uncovered stent deployment (1.00% vs. 1.26%). Covered stents were more effective by 0.0013 Quality-Adjusted Life Years (Standard Deviation [SD] 0.0013 Quality-Adjusted Life Years). They were also less expensive by $729.58 (SD $390.63). Probabilistic sensitivity analysis suggested that these results were not sensitive to model parameter uncertainty. Plastic stents deployment was $2832.64 (SD $1182.72) more expensive than uncovered metal stent deployment. Value of Information analysis suggests that the maximum value of further research in the UK is $61,124.30. The results of this study represent strong evidence for the cost-effectiveness of covered compared with uncovered self-expanding metal stents for the palliation of patients with malignant dysphagia. The findings support previously published literature asserting the dominance of self-expanding metal stents over plastic stents. Value of Information analysis suggests that further research may not be cost-effective. These findings have significant implication for both current clinical practice and future clinical research.

[1]  Stephen S. Lim,et al.  Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs , 2007, The Lancet.

[2]  M. Sculpher,et al.  Decision Modelling for Health Economic Evaluation , 2006 .

[3]  A. Darzi,et al.  Is minimally invasive harvesting of the great saphenous vein for coronary artery bypass surgery a cost-effective technique? , 2008, The Journal of thoracic and cardiovascular surgery.

[4]  A. Darzi,et al.  Cost effectiveness analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery , 2007, BMJ : British Medical Journal.

[5]  J. Farndon,et al.  Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. , 1996, European journal of cancer.

[6]  E. Kuipers,et al.  A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. , 2001, Gastrointestinal endoscopy.

[7]  A. Haycox,et al.  The cost effectiveness of metal oesophageal stenting in malignant disease compared with conventional therapy. , 1999, Clinical Radiology.

[8]  S. Wilson Methods for the economic evaluation of health care programmes , 1987 .

[9]  A. Darzi,et al.  Evidence-Based Choice of Esophageal Stent for the Palliative Management of Malignant Dysphagia , 2008, World Journal of Surgery.

[10]  E. Steyerberg,et al.  Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy. , 2004, European journal of cancer.

[11]  R. Kozarek,et al.  Expandable versus conventional esophageal prostheses: easier insertion may not preclude subsequent stent-related problems. , 1995, Gastrointestinal endoscopy.

[12]  N. Vakil,et al.  A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. , 1993, The New England journal of medicine.

[13]  Liming Cai,et al.  Health, life expectancy, and health care spending among the elderly. , 2003, The New England journal of medicine.

[14]  M. Stelzner,et al.  Surgical therapy of oesophageal carcinoma , 1990, The British journal of surgery.

[15]  S. White,et al.  A cost-benefit comparison of self-expanding metal stents and Atkinson tubes for the palliation of obstructing esophageal tumors. , 1998, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[16]  P. Goggin,et al.  Metal stents improve dysphagia, nutrition and survival in malignant oesophageal stenosis: a randomized controlled trial comparing modified Gianturco Z-stents with plastic Atkinson tubes. , 1998, European journal of gastroenterology & hepatology.

[17]  Karl Claxton,et al.  A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence , 2005 .

[18]  Ara Darzi,et al.  Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery , 2007, BMJ : British Medical Journal.

[19]  Fumie Yokota,et al.  Value of Information Literature Analysis: A Review of Applications in Health Risk Management , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

[20]  G. Murray,et al.  Randomized clinical trial comparing self‐expanding metallic stents with plastic endoprostheses in the palliation of oesophageal cancer , 2002, The British journal of surgery.

[21]  W. Hop,et al.  Quality of Life in patients with resected oesophageal cancer. , 1992, Social science & medicine.

[22]  W. Allum,et al.  Guidelines for the management of oesophageal and gastric cancer , 2002, Gut.

[23]  D. Cunningham,et al.  Guidelines for the management of oesophageal and gastric cancer , 2002, Gut.

[24]  P. Roderick,et al.  The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. , 2003, Health Technology Assessment.

[25]  M Sculpher,et al.  A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. , 2004, Health technology assessment.

[26]  L. Loizou,et al.  A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia , 1992, Cancer.

[27]  Robert L Kane,et al.  Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. , 2007, JAMA.

[28]  W. Hop,et al.  Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. , 1998, Gastrointestinal endoscopy.

[29]  Quality of life measurement in patients with oesophageal cancer. , 1995, Gut.

[30]  G. Apolone,et al.  Evaluation of Quality of Life in Patients with Malignant Dysphagia , 2000, Tumori.

[31]  G. D. De Palma,et al.  Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. , 1996, Gastrointestinal endoscopy.

[32]  G. Sanders,et al.  Cost-effectiveness of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. , 2004, Gastrointestinal endoscopy.

[33]  R. Earlam,et al.  Oesophageal squamous cell carcinoma: I. A critical review of surgery , 1980, The British journal of surgery.

[34]  A. Mclarty,et al.  Esophageal resection for cancer of the esophagus: long-term function and quality of life. , 1997, The Annals of thoracic surgery.

[35]  J. Bond,et al.  Measuring quality of life and utilities in esophageal cancer , 2003, Expert review of pharmacoeconomics & outcomes research.

[36]  Karl Claxton,et al.  The Value of Implementation and the Value of Information: Combined and Uneven Development , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[37]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .